Archives: Resources
Recent Trends in Drug Safety: The Growing and Evolving Role of Real-World Evidence
Review evolving safety studies, recent FDA and EMA guidelines, regulatory shifts, new RWD approaches, and future post-marketing safety study expectations.
Overcoming Challenges in Real-World External Control Arm Design
Read our white paper on real-world external control arms design factors for ECAs to ensure minimal bias and results reflective of the investigated clinical outcomes.
The Evolution of Technology Enablement in Long-term Follow-up Studies
Explore how automated data capture and real-world data (RWD) technologies can optimize LTFU study design and improve real-world evidence (RWE) generation, addressing key challenges and enhancing study continuity.
Advancing Patient-centered Approaches to Oncology Studies
This paper explores decentralized oncology studies to improve patient recruitment and retention, addresses associated challenges, and presents a case study on minimizing COVID-19 exposure during cancer treatment research.
Network Meta-Analysis of Real-World Evidence: The Challenge of Related Publications
In this white paper, we discuss the challenge of including multiple related publications per database in NMAs of RWE.
The Importance of an Implementation Lead within FSP Models
Read more about how implementation leads keep our FSP projects a step ahead
